SCHEMBL39025

SCHEMBL39025

CCc1c(O)cc(O)cc1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
ALOX5 P09917 1/20 0.45
PTGS2 P35354 1/20 0.45
ALDH1A1 P00352 1/20 0.45
TSHR P16473 1/20 0.45
PTPN1 P18031 2/20 0.44
PTPN11 Q06124 2/20 0.44
CYP3A4 P08684 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
PTGS1 P23219 1/20 0.44
DRD3 P35462 1/20 0.44
ACHE P22303 1/20 0.42
KAT8 Q9H7Z6 2/20 0.40
HSP90AB1 P08238 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL39033 0.85 PTPN1 (0.54) CA12CA1CA2CA7CA9
SCHEMBL544300 0.82 CYP3A4 (0.46) CA12CA1CA2CA7CA9
SCHEMBL39571 0.82 KAT8 (0.50) PTPN1PTPN11CYP3A4ACHEKAT8
SCHEMBL10316036 0.81 KDM4E (0.48) PTGS2ALDH1A1PTPN1CYP3A4MEN1
SCHEMBL6264812 0.81 GABRP (0.42) CA12CA1CA2CA7CA9
SCHEMBL22297220 0.81 AKR1C3 (0.48) TSHRPTPN1KAT8PPARAHPGD
SCHEMBL3392969 0.80 CA2 (0.45) CA12CA1CA2CA7CA9
SCHEMBL19433087 0.79 CA12 (0.53) CA12CA1CA2CA7CA9
SCHEMBL39761 0.79 CA12 (0.41) CA12CA1CA2CA7CA9
Grevillol SCHEMBL31345744 0.79 KAT8 (0.59) ALOX5PTGS2TSHRPTPN1PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3320018-B1 POLYCARBONATE COMPOSITIONS WITH IMPROVED FLAME RETARDANCE SHPP GLOBAL TECH BV (NL) 2022-08-10 EP claimed
US-10597530-B2 Polycarbonate compositions with improved flame retardance SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2020-03-24 US claimed
US-20180223097-A1 POLYCARBONATE COMPOSITIONS WITH IMPROVED FLAME RETARDANCE SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2018-08-09 US claimed
EP-3320018-A1 POLYCARBONATE COMPOSITIONS WITH IMPROVED FLAME RETARDANCE SABIC Global Technologies B.V. (NL) 2018-05-16 EP claimed
CN-107849229-A Polycarbonate compositions with improved anti-flammability 沙特基础工业全球技术有限公司 2018-03-27 CN claimed
WO-2017007562-A1 POLYCARBONATE COMPOSITIONS WITH IMPROVED FLAME RETARDANCE SABIC GLOBAL TECHNOLOGIES B. V. (NL) 2017-01-12 WO claimed
EP-1041448-B1 Method for decoloring TOSHIBA KK (JP) 2006-06-07 EP claimed
EP-4680027-A1 A METHOD FOR IMPARTING ANTIMICROBIAL PROPERTIES TO A SYNTHETIC SUBSTRATE Biocompatibility Innovation Srl (IT) 2026-01-21 EP disclosed
WO-2024189407-A1 A METHOD FOR IMPARTING ANTIMICROBIAL PROPERTIES TO A SYNTHETIC SUBSTRATE Biocompatibility Innovation S.r.l. (IT) 2024-09-19 WO disclosed
WO-2023021961-A1 POLYIMIDE PRECURSOR COMPOSITION, POLYIMIDE RESIN, AND CIRCUIT SUBSTRATE 日東電工株式会社 2023-02-23 WO disclosed
EP-3320018-B1 POLYCARBONATE COMPOSITIONS WITH IMPROVED FLAME RETARDANCE SHPP GLOBAL TECH BV (NL) 2022-08-10 EP disclosed
US-11129781-B2 Agent for hair deforming treatment KAO CORPORATION (JP) 2021-09-28 US disclosed
US-11045402-B2 Hair cosmetic composition KAO CORPORATION (JP) 2021-06-29 US disclosed
WO-2008016811-A2 AMINOPIPERIDINES AND REALTED COMPOUNDS NEUROGEN CORPORATION (US) 2008-02-07 WO disclosed
US-20070293669-A1 Invertible amphiphilic polymers UNIVERSITY OF MASSACHUSETTS 2007-12-20 US disclosed
EP-1807408-A1 OXY SUBSTITUTED FLAVONES AS ANTIHYPERGLYCEMIC AND ANTIDYSLIPIDEMIC AGENTS Council of Scientific and Industrial Research (IN) 2007-07-18 EP disclosed
EP-1778614-A2 INVERTIBLE AMPHIPHILIC POLYMERS University of Massachusetts (US) 2007-05-02 EP disclosed
WO-2006093525-A2 INVERTIBLE AMPHIPHILIC POLYMERS UNIVERSITY OF MASSACHUSETTS (US) 2006-09-08 WO disclosed
US-20060178373-A1 Oxy substituted flavones as antihyperglycemic and antidyslipidemic agents COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2006-08-10 US disclosed
WO-2006040621-A1 OXY SUBSTITUTED FLAVONES AS ANTIHYPERGLYCEMIC AND ANTIDYSLIPIDEMIC AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2006-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293669-A1 Invertible amphiphilic polymers PHOSPHO1, INF2, AQP1 CA12 585/4885CA1 578/4885CA2 1299/4885
US-11045402-B2 Hair cosmetic composition CUTA, GRHPR, POLR1C CA12 720/4885CA1 1259/4885CA2 428/4885
US-20060178373-A1 Oxy substituted flavones as antihyperglycemic and antidyslipidemic agents GPR119, LIPC, SLC5A2 CA12 4504/4885CA1 4698/4885CA2 2081/4885
US-11129781-B2 Agent for hair deforming treatment GRHPR, SLC26A4, COL1A1 CA12 1628/4885CA1 1454/4885CA2 739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.